EVIO, Inc. Enters into Letter of Intent to Acquire Leading Edge Pharms, Inc.
Cannabis Law Report
JULY 13, 2021
LEP is a biotechnology company focused on the research, development, and commercialization of novel cannabinoid therapies and innovative drug delivery systems that provide safe and effective topical solutions for pain management. is a provider of analytical testing services for cannabis, hemp, and CBD products. About EVIO Inc.
Let's personalize your content